Insights

Global Manufacturing Footprint Seqens operates 16 manufacturing plants and 9 R&D centers across Europe, North America, and Asia, indicating widespread production capabilities and potential for international collaboration or supply chain expansion to meet diverse customer needs.

Innovation in Sustainability The company recently launched biobased skincare ingredients like AdvensProtect 2-EHG Green and Caprylyl Glycol, demonstrating a strong focus on sustainable, eco-friendly products, which could appeal to clients looking to develop green formulations.

Market Engagement & Events Active participation in major trade events such as InCosmetics Asia and PCHI Guangzhou suggests opportunities to connect directly with formulators, brand owners, and distributors seeking advanced pharmaceutical solutions or specialty ingredients.

Recent Leadership Change The appointment of Pascal Villemagne as CEO signals potential strategic shifts and new business development initiatives, creating openings for partners aligned with the company's evolving vision and growth plans.

Expanding Product Portfolio Seqens' recent launches of biobased ingredients indicate a growing focus on specialty and active ingredients suitable for personal care and pharmaceutical markets, presenting opportunities to collaborate on new product development projects.

SEQENS Tech Stack

SEQENS uses 8 technology products and services including EIA, D2L Brightspace, Data Version Control, and more. Explore SEQENS's tech stack below.

EIA

Advanced Analytics And Data Science

D2L Brightspace

Communication And Collaboration

Data Version Control

Development

Nacelle

E-commerce

ADP Workforce Now

Human Capital Management

Microsoft

Miscellaneous

SpendMap

Sales

Yoast SEO

Search Engines

SEQENS Email Formats	Example	Percentage
First.Last@seqens.com	John.Doe@seqens.com	88%
FLast@seqens.com	JDoe@seqens.com	11%
First.L@seqens.com	John.D@seqens.com	1%

SEQENS Email Formats

Example

Percentage

First.Last@seqens.com

John.Doe@seqens.com

88%

FLast@seqens.com

JDoe@seqens.com

11%

First.L@seqens.com

John.D@seqens.com

Frequently Asked Questions

Where is SEQENS's headquarters located?

SEQENS's main headquarters is located at 21 Chemin de la Sauvegarde Écully, Auvergne-rhône-alpes 69130 France. The company has employees across 4 continents, including EuropeAsiaNorth America.

What is SEQENS's official website and social media links?

SEQENS's official website is seqens.com and has social profiles on LinkedIn Crunchbase.

What is SEQENS's NAICS code?

SEQENS's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does SEQENS have currently?

As of February 2026, SEQENS has approximately 1.3K employees across 4 continents, including EuropeAsiaNorth America. Key team members include Ceo Wavelength Pharmaceuticals, General Manager Seqens Israel: I. A.Ceo: P. C.Chief Procurement Officer: C. D.. Explore SEQENS's employee directory with LeadIQ.

What industry does SEQENS belong to?

SEQENS operates in the Pharmaceutical Manufacturing industry.

What technology does SEQENS use?

SEQENS's tech stack includes EIAD2L BrightspaceData Version ControlNacelleADP Workforce NowMicrosoftSpendMapYoast SEO.

What is SEQENS's email format?

SEQENS's email format typically follows the pattern of First.Last@seqens.com. Find more SEQENS email formats with LeadIQ.

When was SEQENS founded?

SEQENS was founded in 2003.

SEQENS

Q: What is SEQENS's official website and social media links?

SEQENS's official website is seqens.com. SEQENS has social profiles on LinkedIn.

Q: How many employees does SEQENS have currently?

SEQENS has approximately 1.3K employees.

Q: What technology does SEQENS use?

SEQENS's tech stack includes PHP, D2L Brightspace, QlikView, Python, jsDelivr.

Pharmaceutical ManufacturingAuvergne-rhône-alpes, France1001-5000 Employees

SEQENS is a worldwide leader in pharmaceutical solutions and specialty ingredients. 

The group generates a revenue of 1 MM€ and operates 16 manufacturing plants and 9 R&D centers in Europe, North America and Asia. 3,300 employees contribute to the success of SEQENS, among which 350 scientists, engineers and experts who develop tailor-made solutions for our customers.

SEQENS is an integrated player offering a broad portfolio of active ingredients, pharmaceutical intermediates and specialty ingredients. We develop and industrialize the most demanding molecules, and rely on our ability to innovate, develop and implement the best available technologies.

Insights

Similar companies to SEQENS

Vertellus

BASF

Roche

Dow

Novasep

Evonik

Lonza

Sumitomo Chemical

Novartis

Mintek

SEQENS Tech Stack

Media & News

Seqens Group attends event InCosmetics Asia.

Seqens Group launches AdvensProtect 2-EHG Green.

Seqens Group hired Pascal Villemagne as Chief Executive Officer on Apr 1st '25.

Seqens Group launches Caprylyl Glycol.

Seqens Group attends event PCHI 2025 trade fair.

Aether Industries partners with Seqens Group.

Seqens Group partners with Holcim.

SEQENS's Email Address Formats